Buy Olaparib Tablets 150 mg | Oncology Supply – Gilla Pharma
Olaparib 150 mg Tablets are an oral PARP inhibitor indicated for the treatment of BRCA-mutated ovarian, breast, pancreatic, and prostate cancers. This targeted therapy works by blocking DNA repair mechanisms in cancer cells, leading to tumor cell death and delayed disease progression.
Olaparib is commonly used as maintenance therapy following platinum-based chemotherapy and is a cornerstone treatment in BRCA-associated malignancies.
Key Features:
- Strength: 150 mg
- Dosage Form: Oral Tablets
- Drug Class: PARP Inhibitor
- Indications: BRCA-mutated ovarian, breast, pancreatic, and prostate cancers
- Standard Dose: 300 mg twice daily
Why Choose Gilla Pharma?
Gilla Pharma supplies high-quality oncology medicines across Myanmar, Vietnam, Cambodia, Laos, and Indonesia, ensuring:
- Reliable sourcing
- Competitive wholesale pricing
- Regulatory-compliant documentation
- Secure international distribution
We supply exclusively to licensed hospitals, oncology centers, and authorized healthcare providers.
Product Specifications
| Attribute | Details |
|---|---|
| Generic Name | Olaparib |
| Strength | 150 mg |
| Dosage Form | Film-Coated Tablets |
| Therapeutic Class | PARP Inhibitor |
| Indications | BRCA-mutated cancers |
| Route | Oral |
Request a Quote for Olaparib Tablets 150 mg
For bulk supply, pricing, or regulatory documentation, contact Gilla Pharma today.
📩 Email: info@gillapharma.com
📞 Phone: +91 95491 32929 | +84 7645 21324
